Alexander C. Liu

Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice

R. Lawn, D. Grainger, J. Metcalfe, 1994, Nature.

Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis

B. Furie, M. Aronovitz, R. Lawn, 1995, Nature Medicine.

Modulation of In Vivo Fibrinolysis by Apolipoprotein(A) Expression in Transgenic Mice

B. Furie, M. Aronovitz, R. Lawn, 1996 .

The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis

A. Grace, R. Lawn, D. Grainger, 1995, Nature Medicine.

5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family.

R. Lawn, D. Wade, K. Schwartz, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice.

E. Rubin, R. Lawn, J. Verstuyft, 1994, Journal of lipid research.

Angiosarcoma of the face and scalp.

J. Rosen, D. Kapp, B. Egbert, 1990, Annals of plastic surgery.

Lipoprotein(a) and atherogenesis.

R. Lawn, Alexander C. Liu, A. C. Liu, 1994, Trends in cardiovascular medicine.